Company Performance Metrics
- Alberto Venturelli: President and Owner
TYDOCK PHARMA Srl is a knowledge-based biotechnology SME set up in 2006. In 2009, it received an award for being one of the most promising and innovative biotechnology companies in Italy from The Italian Institute for Foreign Trade (I.C.E.).
The company is based on integrated drug discovery know-how which relies on 20 years of experience. It is a
leading player in the drug discovery field and has seen many collaborations with universities and other biotechnology companies.
The Company, as Research and Technology Transfer Centre, is also the recipient of research grants from the European Commission (FP7).
TYDOCK PHARMA mainly operates in two business areas:
DRUG DISCOVERY PRODUCTS
TYDOCK PHARMA focuses on the discovery and early development of chemotherapeutic drugs, with particular emphasis on parasitic diseases (tuberculosis, malaria and protozoarian infections).
INNOVATION PROJECT DEVELOPMENT
TYDOCK PHARMA is involved in various technology transfer projects aimed at translating innovative technologies from basic research to industrial application.
